Thomas Dubin

Thomas Dubin

Director/Board Member at INTENSITY THERAPEUTICS, INC.

Net worth: - $ as of 31/05/2026

64 year
Health Technology
Consumer Services
Commercial Services

Profile

Thomas I.
H.
Dubin
is Executive Chairman at Cellphire, Inc., Director at Norwalk Health Services Corp., Independent Director at Intensity Therapeutics, Inc. since 2024, and Member at Yale School of Public Health.
Former roles include Independent Director at Bioblast Pharma Ltd. from 2015 to 2018, Independent Director at Notable Labs Ltd. from 2023 to 2024, Assistant General Counsel-Pharmaceuticals at Warner-Lambert Co. from 1992 to 1999, Secretary, Vice President & General Counsel at ChiRex, Inc. from 1999 to 2000, Chief Legal Officer, Senior VP & General Counsel at Alexion Pharmaceuticals, Inc. in 2011, Corporate Attorney at Cravath, Swaine & Moore LLP, and Treasurer & Trustee at American Jewish World Service, Inc. Education includes graduate studies at Yale University and New York University School of Law, and undergraduate studies at Amherst College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/04/2026 0 ( -.--% ) - $ 31/05/2026

Thomas Dubin active positions

CompaniesPositionStart
INTENSITY THERAPEUTICS, INC. Director/Board Member 14/05/2024
Director/Board Member -
Chairman -
Corporate Officer/Principal -

Former positions of Thomas Dubin

CompaniesPositionEnd
Director/Board Member 31/07/2018
ALEXION PHARMACEUTICALS, INC. General Counsel -
General Counsel 01/09/2000
Corporate Officer/Principal 01/01/1999
See the detail of Thomas Dubin's experience

Training of Thomas Dubin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Consumer Services

Commercial Services

Consumer Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!